Sponsor or institution

Clinical trials and research at Debiopharm International SA

• 6Clinical trials
• 23Countries

Newest trials

All recruiting trials (6)

• Renal function and afabicin; how kidney health changes drug levels

  This trial tests how different levels of kidney function affect the blood levels of afabicin given as a pill or IV after a single dose.

  Recruiting Phase 1 Debiopharm International SA · Berlin · NCT07758608

• First human testing of oral Debio 1453P in healthy adults

  This trial will test whether single and repeated oral doses of Debio 1453P are safe, well tolerated, and how the body processes them in healthy adults aged 18–55.

  Recruiting Phase 1 Debiopharm International SA · Edegem · NCT07035769

• Debio 1562M for people with relapsed or refractory acute myeloid leukemia

  This trial will try Debio 1562M to see if it is safe and can fight leukemia in people with relapsed or refractory AML who have no standard treatment options.

  Recruiting at 7 sites Phase 1/2 Debiopharm International SA · Duarte, California and 6 other locations · NCT06969430

• Assessing Debio 4126 for treating acromegaly in patients on somatostatin analogs

  This study is testing if a new treatment called Debio 4126 can help people with acromegaly who are already on somatostatin analogs keep their IGF-1 levels in check better than a placebo.

  Recruiting at 72 sites Phase 3 Debiopharm International SA · Los Angeles, California and 73 other locations · NCT06930625

• Combining Debio 0123 with Temozolomide for Glioblastoma Treatment

  This study is testing if a new drug called Debio 0123, when combined with the standard treatment temozolomide, can help adults with glioblastoma feel better and improve their outcomes.

  Recruiting at 16 sites Phase 1/2 Debiopharm International SA · Chicago, Illinois and 15 other locations · NCT05765812

• Testing RP-6306 alone or with other drugs in patients with advanced solid tumors

  This study is testing a new drug called RP-6306, alone and with other medications, to see how safe it is and if it can help people with advanced solid tumors.

  Recruiting at 19 sites Phase 1 Debiopharm International SA · Los Angeles, California and 25 other locations · NCT04855656

Quick answers

How many clinical trials run by Debiopharm International SA are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 23 countries. The most sites are in United States (4 trials), Spain (3 trials), Germany (2 trials), Belgium (2 trials), Denmark (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 1/2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →